TrialPath
Recruiting

A Novel Digital Music-based Autonomous Personalized Walking Intervention to Improve Gait and Walking Automaticity in Parkinson Disease

NCT07705373 · Boston University Charles River Campus
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

About this study
The overall goal of this single-arm, multi-center repeated baselines study (N=162) is to examine how a personalized closed-loop music-based digital gait intervention, using MR-005 (MedRhythms, Inc.), improves gait quality, capacity, real-world walking performance, and gait automaticity in Parkinson disease (PD). Participants will complete a community-based, self-directed walking program using the digital music-based device 4 days a week for 12 weeks, designed to promote sustained walking beyond the use of the device. This study builds on a stepwise investigation beginning with a proof-of-concept feasibility study (N=23) followed by a 6-week randomized controlled trial (RCT; N=44). This mechanistic-focused study will examine the substrates of a personalized approach that underlie changes in walking outcomes, as well as identify determinants that determine responsiveness to the intervention. This study is a critical next step to elucidate mechanistic understanding of closed-loop personalized gait approaches and to determine those with PD who benefit most.
Eligibility criteria
Inclusion Criteria: * Self-report of diagnosis of typical Parkinson disease determined by a medical doctor * ≥ 40 years of age * Community-dwelling (e.g. home, independent living, senior housing) * Have stable PD medications for at least two weeks prior to enrollment * Modified Hoehn and Yahr stages 1-3 per physical exam by a licensed physical therapist * Able to walk independently without physical assistance for at least 10 minutes (assistive devices allowed with reciprocal gait pattern) * Willing and able to provide informed consent * Provide HIPAA Authorization to allow communication with the primary healthcare provider for communication (as needed) during the study period Exclusion Criteria: * \< 40 years of age * Diagnosis of atypical Parkinsonism * Modified Hoehn and Yahr stages 4-5 * Significantly disturbing freezing episodes during daily walking based on the New Freezing of Gait Questionnaire (Part III Item 7) * Fall frequencies \>1x/week on average, over the past month. * Currently participating in physical therapy for Parkinson gait rehabilitation * Currently performing walking exercise at moderate intensities or higher for at least 30 min. per session ≥ 3x/week * Self-reported cardiac problems that interfere with the ability to safely exercise (e.g., congestive heart failure, uncontrolled cardiac arrhythmias, chest pain; * Orthopedic problems in the lower extremities or spine that may limit walking distance (e.g., severe arthritis, spinal stenosis, or significant pain) * Any other medical conditions that would preclude successful participation as determined by the researcher/ physical therapist * Cognitive impairment (i.e., Montreal Cognitive Assessment, MoCA \< 21) * Unable to walk independently (i.e., without physical assistance) at a comfortable speed ≥ 0.4m/s as measured using the 10-meter Walk Test (10mWT) as examined in Baseline #1 * Resting tachycardia (\> 100 beats/min) or uncontrolled blood pressure (resting systolic BP \> 160 mmHg or diastolic BP \>100 mmHg)) as measured by the researcher/ physical therapist * Unable to independently use the music-based digital therapeutic during training * Significant hearing impairment
Study design
Enrollment target: 200 participants
Allocation: na
Masking: none
Age groups: adult, older_adult
Timeline
Starts: 2026-08-20
Estimated completion: 2029-02-28
Last updated: 2026-08-24
Interventions
Device: MR-005 (MedRhythms, Inc., Portland, ME)
Primary outcomes
  • • Minutes of Moderate Intensity Walking (Baseline 1)
  • • Minutes of Moderate Intensity Walking (Baseline 2 (2-3 weeks after Baseline 1))
  • • Minutes of Moderate Intensity Walking (Immediately after the intervention (about 3 months))
Sponsor
Boston University Charles River Campus · other
With: Michael J. Fox Foundation for Parkinson's Research, University of Utah, Washington University School of Medicine
Contacts & investigators
ContactErica Clarke, BS · contact · egclarke@bu.edu · 617-358-6157
ContactFranchino Porciuncula, EdD PT DScPT · contact · fporciun@bu.edu · 617-353-7571
InvestigatorTerry D. Ellis, PhD PT · principal_investigator, Boston University Center for Neurorehabilitation
All locations (3)
Boston University Center for NeurorehabilitationRecruiting
Boston, Massachusetts, United States
Washington University School of MedicineRecruiting
St Louis, Missouri, United States
University of UtahRecruiting
Salt Lake City, Utah, United States
A Novel Digital Music-based Autonomous Personalized Walking Intervention to Improve Gait and Walking Automaticity in Parkinson Disease · TrialPath